Equity and Cash Incentive Program - SARs Activity (Details) - Stock Appreciation Rights (SARs) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Number of Shares
Outstanding, beginning balance (in shares)	2,409,610
Granted (in shares)	355,685	359,715	335,285
Forfeited/expired (in shares)	(53,889)
Exercised (in shares)	(309,760)
Outstanding, ending balance (in shares)	2,401,646	2,409,610
Exercisable (in shares)	1,468,033
Weighted Average Exercise Price
Beginning balance (in dollars per share)	$ 109.65
Granted (in dollars per share)	160.11	$ 153.25	$ 160.21
Forfeited/Expired (in dollars per share)	157.74
Exercised (in dollars per share)	86.27
Ending balance (in dollars per share)	119.11	$ 109.65
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 94.54
Weighted Average Remaining Contractual Term (Years)
Outstanding	5 years 7 months 6 days
Exercisable	4 years
Outstanding, Aggregate Intrinsic Value	$ 164,481
Exercisable, Aggregate Intrinsic Value	$ 136,613